Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.


TSXV:CLAS.H - Post by User

Post by tillbillyon Feb 29, 2012 8:03am
485 Views
Post# 19602894

Sprott Woulda Sold

Sprott Woulda Sold

This news will come as no surprise to Eric (Sprott)....know this....His ear will be close to his investment. Had this been bad news (this is for you blue) this stock would of sold down this past 2 weeks.Down 2 cents up 1 cent, until he was out. The volume does not represent this.

If this stock gaps down this Am you will want to add, they will shake you out of your frightened loose shares.

I doubt you will get your 15 cents back today but you will get a chance at 12. If your patient and wait another year you will profit. My question to you (and others including myself) is when you paid 15(or more in my case) What was your thesis? When I bought I was purely speculating on a Comp with no earnings.. Now, if the NR is to be believed, they have funding (assuming they are budjeting corectly) to continue growing and perhaps turn a profit should this latest well prove out favorably. Wait 2years on your massive investment and see how it plays out.

 I'll add any dip below 8

Bullboard Posts